Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

psoriasis
News
Systemic Immunity-Inflammation Index Associated With Psoriasis
06/20/2024
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
psoriatic arthritis
News
Readmissions After Hospitalization for Psoriatic Arthritis
06/20/2024
Researchers aimed to assess the rates, characteristics, and predictors of 30-day readmissions among adults hospitalized for psoriatic arthritis across the United States.
Researchers aimed to assess the rates, characteristics, and predictors of 30-day readmissions among adults hospitalized for psoriatic arthritis across the United States.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
Atopic dermatitis
News
Lebrikizumab for Moderate to Severe Atopic Dermatitis in Patients Age ≥60 Years
06/20/2024
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD)...
06/20/2024
The Dermatologist

Advertisement

AD
News
Ruxolitinib Cream for Patients With Facial and/or Neck Atopic Dermatitis
06/19/2024
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at...
06/19/2024
The Dermatologist
vitiligo
News
Vitiligo Biomarker CXCL10 Correlation With Clinical Response
06/18/2024
During the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, presenters showcased how ruxolitinib cream, a topical Janus kinase 1/JAK2 inhibitor, is the first US Food and Drug Administration and European Commission-approved...
During the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, presenters showcased how ruxolitinib cream, a topical Janus kinase 1/JAK2 inhibitor, is the first US Food and Drug Administration and European Commission-approved...
During the Revolutionizing...
06/18/2024
The Dermatologist
SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist

Advertisement

social media
News
Real-world Insights: Physician-assessed and Patient-reported Outcomes in Atopic Dermatitis Patients Treated with Dupilumab
06/16/2024
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the GLOBOSTAD study offered valuable insights into the real-world effectiveness of dupilumab, a promising treatment for atopic dermatitis.
A recent update from the...
06/16/2024
The Dermatologist
AD
News
Efficacy of Targeted Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Network Meta-Analysis
06/15/2024
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in...
06/15/2024
The Dermatologist
medical bill
News
Identifying Candidates for Systemic Therapy in Atopic Dermatitis: A Practical Checklist
06/14/2024
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the,...
06/14/2024
The Dermatologist

Advertisement

AD
News
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis
06/13/2024
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on...
06/13/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Spotlight
A Conversation With Susan C. Taylor, MD
07/16/2021
Dr Taylor is a leading voice for the scientific research, clinical care, and education for the dermatologic health of underserved populations
Dr Taylor is a leading voice for the scientific research, clinical care, and education for the dermatologic health of underserved populations
Dr Taylor is a leading voice for...
07/16/2021
The Dermatologist
Chief Medical Editor Message
Brand vs. Generic
03/31/2011
New drugs are wonderful, providing dermatologists new options to offer patients. The period of exclusivity offered by patent protection provides pharmaceutical companies a strong incentive to develop novel products that are better than those...
New drugs are wonderful, providing dermatologists new options to offer patients. The period of exclusivity offered by patent protection provides pharmaceutical companies a strong incentive to develop novel products that are better than those...
New drugs are wonderful,...
03/31/2011
The Dermatologist
Dr Elbuluk
Q&As
Image Innovation: Q&A With Dr Nada Elbuluk on Project IMPACT
09/15/2021
Dr Elbuluk discussed health equity, Project IMPACT, and how clinical images can pave the way to improve dermatologic care for racial-ethnic minorities.
Dr Elbuluk discussed health equity, Project IMPACT, and how clinical images can pave the way to improve dermatologic care for racial-ethnic minorities.
Dr Elbuluk discussed health...
09/15/2021
The Dermatologist
Derm Dx
What is This Hypertrichotic Lesion?
01/31/2011
A 47-year-old Caucasian man presented with a large brown, hairy lesion localized to the right shoulder. The patient stated that the lesion became apparent several years ago and progressively darkened and enlarged to its current status. The...
A 47-year-old Caucasian man presented with a large brown, hairy lesion localized to the right shoulder. The patient stated that the lesion became apparent several years ago and progressively darkened and enlarged to its current status. The...
A 47-year-old Caucasian man...
01/31/2011
The Dermatologist
Q&As
CPC: Advice From a Dermatologist-Dermatopathologist
08/16/2021
Clinicopathologic correlation (CPC) depends on alignment between a clinical diagnosis and the histopathologic findings of a biopsy. Dr Kiran Motaparthi shares how to improve CPC and the communication between dermatologist and...
Clinicopathologic correlation (CPC) depends on alignment between a clinical diagnosis and the histopathologic findings of a biopsy. Dr Kiran Motaparthi shares how to improve CPC and the communication between dermatologist and...
Clinicopathologic correlation...
08/16/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use